(300677.SZ) plans to launch a restricted stock incentive plan in 2025.

Zhtng Cijng APP News, Yingke Medical (300677.SZ) announced the 2025 Restricted Stock Incentive Plan (draft), intending to grant a total of no more than 13.592 million restricted stocks to the incentive objects, accounting for 2.10% of the total company's stock capital at the time of the announcement of this draft incentive plan. Among them, 13.222 million stocks will be granted for the first time, with 0.37 million stocks reserved. The grant price (including the reserved stocks) is 11.40 yuan per share.